<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>48(3)</volume><submitter>Yasmin F</submitter><funding>This study was supported by Qatar National Library.</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Recent guidelines for acute coronary syndrome (ACS) with multivessel coronary artery disease (MVD) recommend revascularization of non-culprit lesions following primary percutaneous coronary intervention (PCI). However, the optimal timing for this procedure-whether immediate or staged-remains uncertain.&lt;h4>Methods&lt;/h4>A comprehensive search using PubMed (MEDLINE), Cochrane Central, and Google Scholar was conducted to identify studies comparing clinical outcomes between immediate and staged revascularization approaches in patients with MVD undergoing PCI. A random effects model was used to calculate risk ratios (RRs) for dichotomous outcomes with 95% confidence intervals (CIs). The primary outcome was 1-year all-cause mortality.&lt;h4>Results&lt;/h4>A total of 10 randomized controlled trials (RCTs), comprising 3886 patients (1964 in the immediate revascularization group and 1940 in the staged revascularization group), with a median follow-up of 12 months, were included in the analysis. No significant difference in the risk of 1-year mortality was noted between the two approaches. The risk of target vessel revascularization (TVR) at 1-year follow-up was significantly lower in the immediate revascularization group compared to the staged revascularization group (RR: 0.64; 95% CI: 0.47-0.86; I²: 0%; p = 0.03). Additionally, the immediate revascularization group had a significantly lower risk of myocardial infarction (MI) at 1-year follow-up than the staged approach (RR: 0.57; 95% CI: 0.37-0.88; I²: 10%; p = 0.01).&lt;h4>Conclusion&lt;/h4>This meta-analysis suggests that immediate revascularization is associated with a significantly lower risk of TVR and MI at 1-year compared to staged revascularization.</pubmed_abstract><journal>Clinical cardiology</journal><pagination>e70105</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11894271</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical Outcomes of Immediate Versus Staged Revascularization of Nonculprit Arteries in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.</pubmed_title><pmcid>PMC11894271</pmcid><pubmed_authors>Iqbal J</pubmed_authors><pubmed_authors>Surani S</pubmed_authors><pubmed_authors>Sadiq M</pubmed_authors><pubmed_authors>Zaidi SF</pubmed_authors><pubmed_authors>Moeed A</pubmed_authors><pubmed_authors>Shahzad M</pubmed_authors><pubmed_authors>Yasmin F</pubmed_authors><pubmed_authors>Asghar MS</pubmed_authors><pubmed_authors>Alraies MC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical Outcomes of Immediate Versus Staged Revascularization of Nonculprit Arteries in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.</name><description>&lt;h4>Background&lt;/h4>Recent guidelines for acute coronary syndrome (ACS) with multivessel coronary artery disease (MVD) recommend revascularization of non-culprit lesions following primary percutaneous coronary intervention (PCI). However, the optimal timing for this procedure-whether immediate or staged-remains uncertain.&lt;h4>Methods&lt;/h4>A comprehensive search using PubMed (MEDLINE), Cochrane Central, and Google Scholar was conducted to identify studies comparing clinical outcomes between immediate and staged revascularization approaches in patients with MVD undergoing PCI. A random effects model was used to calculate risk ratios (RRs) for dichotomous outcomes with 95% confidence intervals (CIs). The primary outcome was 1-year all-cause mortality.&lt;h4>Results&lt;/h4>A total of 10 randomized controlled trials (RCTs), comprising 3886 patients (1964 in the immediate revascularization group and 1940 in the staged revascularization group), with a median follow-up of 12 months, were included in the analysis. No significant difference in the risk of 1-year mortality was noted between the two approaches. The risk of target vessel revascularization (TVR) at 1-year follow-up was significantly lower in the immediate revascularization group compared to the staged revascularization group (RR: 0.64; 95% CI: 0.47-0.86; I²: 0%; p = 0.03). Additionally, the immediate revascularization group had a significantly lower risk of myocardial infarction (MI) at 1-year follow-up than the staged approach (RR: 0.57; 95% CI: 0.37-0.88; I²: 10%; p = 0.01).&lt;h4>Conclusion&lt;/h4>This meta-analysis suggests that immediate revascularization is associated with a significantly lower risk of TVR and MI at 1-year compared to staged revascularization.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-07-04T03:05:57.025Z</modification><creation>2025-04-20T01:46:42.227Z</creation></dates><accession>S-EPMC11894271</accession><cross_references><pubmed>40065749</pubmed><doi>10.1002/clc.70105</doi></cross_references></HashMap>